# Ascent Pharmaceuticals Inc, Central Islip, NY – FDA Inspections

Source: https://www.keypedia.com/companies/ascent-pharmaceuticals-inc/a6df28ee-9e4e-4fae-8eed-dbe5eb870593

> Inspection records and compliance data for Ascent Pharmaceuticals Inc in Central Islip, New York. 10 FDA inspections on record, last inspected February 03, 2025.

---

## Details

- Name: Ascent Pharmaceuticals Inc
- FEI Number: 3009518416
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK, REPACK
- Address Line 1: 400 S Technology Dr
- City: Central Islip
- State: New York
- Zip Code: 11722
- Country Name: United States
- Address: 400 S Technology Dr, Central Islip, New York 11722, United States
- Country: United States

## Related Documents

- FDA Inspection 1261247 - Ascent Pharmaceuticals Inc - 2025-02-03 — source: FDA, date: February 3, 2025
- [483 - Ascent Pharmaceuticals Inc - 2024-08-09](https://www.keypedia.com/records/483/ascent-pharmaceuticals-inc/b4c3eb9d-fc43-485b-92aa-b15585f5b691) — source: FDA, date: August 9, 2024
- FDA Inspection 1229681 - Ascent Pharmaceuticals Inc - 2024-08-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 9, 2024
- [FDA Inspection 1229681 - Ascent Pharmaceuticals Inc - 2024-08-09](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/ad54fbcb-6020-4316-b662-c5582cc31d0d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 9, 2024
- [EIR - Ascent Pharmaceuticals Inc - 2022-09-15](https://www.keypedia.com/records/eir/ascent-pharmaceuticals-inc/2fb010b3-445b-435d-a436-65bc3ad95991) — source: FDA, date: September 15, 2022
- [483 - Ascent Pharmaceuticals Inc - 2022-09-15](https://www.keypedia.com/records/483/ascent-pharmaceuticals-inc/2e23b981-2208-442a-b00c-5dea4a7b4772) — source: FDA, date: September 15, 2022
- [FDA Inspection 1179615 - Ascent Pharmaceuticals Inc - 2022-09-15](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/23ea7cb5-85bb-4ee6-96ce-1106d4aec03b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 15, 2022
- [EIR - Ascent Pharmaceuticals Inc - 2020-10-13](https://www.keypedia.com/records/eir/ascent-pharmaceuticals-inc/3eaf2db1-5d5f-47da-9d2e-06c2a5c8b70b) — source: FDA, date: October 13, 2020
- [483 - Ascent Pharmaceuticals Inc - 2020-10-13](https://www.keypedia.com/records/483/ascent-pharmaceuticals-inc/b3e18f47-8ed5-4369-97a2-52cd5886bfa7) — source: FDA, date: October 13, 2020
- FDA Inspection 1132410 - Ascent Pharmaceuticals Inc - 2020-10-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 13, 2020
- [EIR - Ascent Pharmaceuticals Inc - 2018-11-07](https://www.keypedia.com/records/eir/ascent-pharmaceuticals-inc/bf03bde7-3589-4d60-bff6-b421b9fbb1b2) — source: FDA, date: November 7, 2018
- [FDA Inspection 1074882 - Ascent Pharmaceuticals Inc - 2018-11-07](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/b6df4373-5d5c-4445-88c2-715ab5b7de63) — classification: No Action Indicated (NAI), source: FDA, date: November 7, 2018
- FDA Inspection 1067030 - Ascent Pharmaceuticals Inc - 2018-07-27 — classification: No Action Indicated (NAI), source: FDA, date: July 27, 2018
- [EIR - Ascent Pharmaceuticals Inc - 2018-02-21](https://www.keypedia.com/records/eir/ascent-pharmaceuticals-inc/08fb764b-023a-4f94-b7fa-d8d8c7e29daf) — source: FDA, date: February 21, 2018
- FDA Inspection 1047500 - Ascent Pharmaceuticals Inc - 2018-02-21 — classification: No Action Indicated (NAI), source: FDA, date: February 21, 2018
- FDA Inspection 949174 - Ascent Pharmaceuticals Inc - 2015-11-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2015
- [FDA Inspection 852064 - Ascent Pharmaceuticals Inc - 2013-09-26](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/357d3b44-3de0-447f-ad5e-4eb4aba15b06) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 26, 2013

## Related Companies

- [NATCO Pharma Limited](https://www.keypedia.com/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/66c964bb-f670-493b-ab86-aa8507e68a5d)
- [Pfizer Healthcare India Private Limited](https://www.keypedia.com/companies/pfizer-healthcare-india-private-limited/50c6f34f-3ef8-4cd6-bd55-6e1ee280d4f7)
- [Aarkish Pharmaceuticals NJ Inc](https://www.keypedia.com/companies/aarkish-pharmaceuticals-nj-inc/62c50ef6-4542-4051-b9f0-04ba004fb177)
- [Modavar Pharmaceuticals](https://www.keypedia.com/companies/modavar-pharmaceuticals/9b63702d-7db4-4738-8b79-5f7fc9cd73d6)
- [Procter & Gamble Manufactura S. de R.L. de C.V.](https://www.keypedia.com/companies/procter-gamble-manufactura-s-de-rl-de-cv/8b78eeab-6efe-4a8d-b98a-c1bfda966646)
- [GRANULES LIFE SCIENCES PRIVATE LIMITED](https://www.keypedia.com/companies/granules-life-sciences-private-limited/434955b0-03c5-4fc0-a6c2-1241872c2974)
- [Ipca Laboratories Limited](https://www.keypedia.com/companies/ipca-laboratories-limited/4221e8f5-a261-45fc-b9fc-d935bc1f225b)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/4fd10a2e-3696-4bd0-82aa-e875143028c0)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/de9dc5de-fbea-4a7d-ab5b-a398b6ed442e)

## Related Officers

- [company_representative](https://www.keypedia.com/people/davies-kochunni/3c6e7ba3-2651-4af8-9bf5-2ee7298d3169)
- [Consumer Safety Officer at FDA](https://www.keypedia.com/people/alice-s-tsao/b6d72ceb-de7c-413d-b104-cac3b075c170)
- [Consumer Safety Officer at FDA](https://www.keypedia.com/people/joy-ann-p-matthias/129f51c0-e0ba-45a9-b4c3-921f0178351a)
- [Investigator ](https://www.keypedia.com/people/karen-l-kosar/6e58be60-f8e3-44f3-8218-8acdde249724)
- [Bijoy Panicker](https://www.keypedia.com/people/bijoy-panicker/1c6ec57f-e02e-49b8-8b59-1853f3d2947a)